Dexelance Balance Sheet Health
Financial Health criteria checks 2/6
Dexelance has a total shareholder equity of €154.2M and total debt of €156.3M, which brings its debt-to-equity ratio to 101.4%. Its total assets and total liabilities are €470.4M and €316.2M respectively. Dexelance's EBIT is €35.0M making its interest coverage ratio 3.3. It has cash and short-term investments of €42.5M.
Key information
101.4%
Debt to equity ratio
€156.35m
Debt
Interest coverage ratio | 3.3x |
Cash | €42.48m |
Equity | €154.22m |
Total liabilities | €316.16m |
Total assets | €470.38m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: QZ2's short term assets (€157.4M) exceed its short term liabilities (€121.5M).
Long Term Liabilities: QZ2's short term assets (€157.4M) do not cover its long term liabilities (€194.6M).
Debt to Equity History and Analysis
Debt Level: QZ2's net debt to equity ratio (73.8%) is considered high.
Reducing Debt: Insufficient data to determine if QZ2's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: QZ2's debt is not well covered by operating cash flow (14.1%).
Interest Coverage: QZ2's interest payments on its debt are well covered by EBIT (3.3x coverage).